Catálogos >
PHC Europe B.V. / PHCbi >
PATHFAST™ - B·R·A·H·M·S PCT Brochure

PATHFAST™ - B·R·A·H·M·S PCT Brochure
1 / 6Páginas

Excertos do catálogo

PATHFAST™ - B·R·A·H·M·S PCT Brochure - 1

Master the challenge in sepsis diagnostic • up to 6 samples in parallel • in less than 17 minutes • out of whole blood, plasma or serum • in high-sensitive central lab quality • for guided antibiotic stewardship cs List on WHO Essential In-vitro Di

Abrir o catálogo na página 1

PATHFAST™ - B·R·A·H·M·S PCT Brochure - 2

PCT in sepsis patients Sepsis with acute organ dysfunction (severe sepsis) is the number one cause of death in the non-coronary intensive care unit and one of the most significant challenges in critical care [1]: Fig. 1: PCT increase reflects the likelihood to develop from a healthy condition to the most severe states of disease (severe sepsis and septic shock) 6 - 9 million people die per year – 1 death every 3-4 seconds Survivors may face lifelong consequences Local infections Systemic infections Severe sepsis PCT plasma concentration (ng/ml) 27 - 30 million people are affected by sepsis...

Abrir o catálogo na página 2

PATHFAST™ - B·R·A·H·M·S PCT Brochure - 3

Specific performance data The test principle of PATHFAST TM B.R.A.H.M.S PCT is based on non-competitive CLEIA combined with MAGTRATION® technology and is standardised against the B.R.A.H.M.S PCT sensitive KRYPTOR assay. During incubation of the sample with alkaline phosphatase labelled anti-PCT monoclonal antibody and antiPCT monoclonal antibody coated magnetic particles, the PCT of the sample binds to the anti-PCT antibodies forming an immune complex with enzyme labelled antibody and antibody coated magnetic particles. After removing the unbound substances by MAGTRATION® technology, a...

Abrir o catálogo na página 3

PATHFAST™ - B·R·A·H·M·S PCT Brochure - 4

Application and benefit of PATHFAST TM B.R.A.H.M.S PCT With its easy and intuitive design, PATHFAST TM offers an easy way to analyse your patient samples by performing only 3 simple steps. Collect whole blood, serum or plasma samples, using heparin-NA, heparin-Li or EDTA collection tubes. Transfer 100 µL sample into each sample well of the reagent cartridges. Due to its reagent design and reagent throughput, PATHFAST TM is designed as an optimal companion combining the quality of results of a central lab analyser with the flexibility of a point of care testing device in one instrument. The...

Abrir o catálogo na página 4

PATHFAST™ - B·R·A·H·M·S PCT Brochure - 5

The Advantage of using a quality B.R.A.H.M.S PCT In order to optimize the process of ED patient flow, a fast decision on a broad spectrum of diseases and injuries helps contribute to a shorter average length of stay in the ED. A reliable, stable and clinically proven diagnostic solution supports the clinical-based decision, lowering patient risk and reducing treatment costs. The application of the B.R.A.H.M.S PCT on the PATHFAST TM system will comply with the highest testing standard possible, and will support the sepsis diagnostic for the future. The clinical reliability of B.R.A.H.M.S PCT...

Abrir o catálogo na página 5

PATHFAST™ - B·R·A·H·M·S PCT Brochure - 6

Product List PATHFAST TM for critical care and sepsis diagnostics Item number Pack size PATHFAST TM pipette tips PATHFAST TM B.R. A.H.M.S PCT control set PATHFAST TM Presepsin control set SYSTEM PATHFAST TM Immunoanalyser Analyzer for the detection of cardiac and other emergency parameters and sepsis CONSUMABLES AND ACCESSORIES REAGENT KITS FOR CRITICAL CARE DIAGNOSTICS REAGENT KITS FOR SEPSIS DIAGNOSTICS PHC Europe B.V. Nijverheidsweg 120, 4879 AZ Etten-Leur, The Netherlands Phone: + 31 76 543 38 33 email: marketing@eu.phchd.com

Abrir o catálogo na página 6